Navigation Links
Qteros Management to Present at Upcoming Conferences in May

MARLBOROUGH, Mass., April 28, 2011 /PRNewswire/ -- Qteros, Inc., the developer of a unique and highly efficient Consolidated Bioprocessing (CBP) platform for the lowest-cost production of cellulosic ethanol, today announced its plans to present at various industry conferences throughout the month of May.

Kevin A. Gray, Ph.D., Senior Vice President and Chief Scientific Officer for Qteros, will deliver an oral presentation at the 33rd Symposium on Biotechnology for Fuels and Chemicals being held at the Sheraton Seattle, Washington. His presentation, "Technology Development and Scale-up of the Production of Lignocellulosic Ethanol using the Microbe Clostridium phytofermentans" will be presented during Session 9: Biofuels and Biorefinery Economics and Sustainability on Tuesday, May 3, 2011 at 1:00pm PDT.

Mick Sawka, Qteros' Senior Vice President of Commercial Development and Engineering, will also present on May 3, 2011 at Thomson Reuters' Open Innovation Seminar. The presentation is scheduled for 8:00am EDT and will be held at Thomson Reuters' offices in Boston, MA.

Dr. Gray will participate in the 2011 World Congress on Industrial Biotechnology & Bioprocessing in Toronto, Ontario, Canada. On Monday, May 9, 2011 at 8:45am EDT, Dr. Gray will deliver a presentation entitled, "Plant Cell Wall Degrading Micro-Organisms as Biocatalysts for Biofuels and Bio-Chemicals Production."  On Tuesday, May 10, 2011, at 9:00am EDT, Dr. Gray will moderate a panel entitled, "Engineering Low Cost Feedstocks to Value-Add Bio-chemicals." He will deliver a presentation during this panel discussion entitled, "Clostridium phytofermentans as an Inexpensive Sugar Platform for Biochemicals."

About Qteros, Inc.
Qteros' mission is to accelerate the global commercialization of large-scale, lowest-cost cellulosic ethanol production. Qteros has teamed with a core group of world-class strategic partners that complement and leverage our advanced microbiology and process engineering expertise. Working closely with its strategic partners, Qteros expects to rapidly scale its highly efficient, lowest-cost Consolidated Bioprocessing (CBP) platform for converting non-food biomass into biofuels. Qteros is funded by leading investors in the alternative energy industry including, among others, Venrock Associates, Battery Ventures, BP AE Ventures, Soros Fund Management LLC, and Valero Energy Corporation. For more information, please visit

Susan Hager
VP Corporate Communications & Government Affairs
(508) 251-6339

SOURCE Qteros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Qteros Management to Present at Alternative Energy Investment Banking Conferences
2. Qteros Management to Present at Notable Alternative Energy Conferences in February
3. Qteros and Praj Industries Announce Broad Strategic Partnership to Accelerate Global Commercialization of Cellulosic Ethanol
4. Qteros and UMass Amherst Announce the Issuance of a U.S. Patent for Production of Ethanol From a Unique Microorganism, the Q Microbe(TM)
5. Biofuels Technology Leader Qteros Names Mick Sawka Vice President, Business Development
6. Biofuels Technology Leader Qteros Names Industry Veteran John McCarthy President and Chief Executive Officer
7. Cellulosic Biofuels Leader Qteros Adds Key Positions
8. Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009
9. Conflict of Interest Management System Selected by Henry Ford Health System
10. Best Practices, LLC Showcases Its Expertise in Customer Relationship Management
11. SPX Announces Acquisition of B.W. Murdoch Ltd, Broadening Process Engineering and Project Management Capabilities in New Zealand and the Asia Pacific Region
Post Your Comments:
(Date:12/1/2015)... Dec. 1, 2015 Today the Allen Institute ... Seattle,s South Lake Union neighborhood, the ... Mercer Street and Westlake Avenue North, the 270,000 square ... Institute for Brain Science and the Allen Institute for ... and founder of the Allen Institute. "We started by ...
(Date:12/1/2015)... Oxford Finance LLC ("Oxford"), a specialty finance ... healthcare services companies, today announced the closing of a ... ("the Company"). Proceeds from the loan are being used ... Rejuvaphyl™ and daily skincare products. --> ... of high potency skincare products that contain the proprietary ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... announces Park NX10 SICM Module, an add-on scanning ion conductance microscopy module to ... of SICM to an AFM. , Park SICM benefits virtually all materials characterization ...
(Date:12/1/2015)... 1, 2015 Cepheid (Nasdaq: CPHD ) ... the Piper Jaffray Healthcare Conference in New ... is reaffirming its outlook for the fourth quarter of ... to discussing longer term business model expectations. ...  "We continue to be the fastest growing company of ...
Breaking Biology Technology:
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has ... of MIT and Harvard for use of its ... information management tools. The partnership will support the ... biological and chemical research information internally and with ... be used for managing the Institute,s electronic laboratory ...
(Date:11/10/2015)... About signature verification Signature ... identify and verify the identity of an individual ... secure and accurate method of authentication and is ... because each individual,s signature is highly unique. Signature ... signature of an individual is compared and matched ...
Breaking Biology News(10 mins):